DecisionHealth, DecisionHealth - 2009 Issue 12 (December)

Benchmark of the Week: High-growth, high-denial drug codes

Summary: Unspecified drug injections are one of the fastest-growing high-denial drugs commonly billed to Medicare, according to a Part B News analysis of the latest CMS claims data. J3490 (drugs unclassified injection) joins J1562 (Vivaglobin), used for patients with primary immunodeficiency and J0878 (Daptomycin injection), used to fight drug-resistant bacterial infections, in our list of 10 high-growth, high-utilization, high-denial drug codes.

To read the full article, sign in and subscribe to the DecisionHealth Newsletters.

Official DecisionHealth® Newsletter Archives includes:

  • Includes over 25,000 articles from:
    • Coder Pink Sheets
    • Part B News
    • Answer Books newsletters
  • Current newsletters added each quarter
  • Timely news and guidance vital for your practice
  • Fully searchable through Find-A-Code's Comprehensive Search
  • Codes mentioned in articles are linked to the Find-A-Code Code Information pages
  • Code Information pages link back to related articles
  • Save yourself tons of research time, find everything in one place!
Access to this feature is available in the following products:
  • DecisionHealth Coding, Billing and Compliance Library

demo
request yours today
 subscribe
start today
 newsletter
free subscription

Thank you for choosing Find-A-Code, please Sign In to remove ads.